浙江九洲药业股份有限公司关于使用闲置募集资金进行现金管理到期赎回并继续进行现金管理的公告

Core Viewpoint - The company, Zhejiang Jiuzhou Pharmaceutical Co., Ltd., has announced the use of idle raised funds for cash management, specifically to redeem maturing cash management products and continue cash management activities [1][2]. Cash Management Overview - The entrusted party for cash management is Agricultural Bank of China, Changshu Economic Development Zone Branch [2]. - The board of directors approved the use of up to RMB 1 billion of idle raised funds for cash management, ensuring that it does not affect the construction and use of investment projects [2][7]. - The cash management products include high-security and liquid investment options such as structured deposits, time deposits, large certificates of deposit, notice deposits, income certificates, and bank or brokerage wealth management products [2][7]. Cash Management Details - The amount used for cash management is RMB 30 million [4][5]. - The cash management product involved is a large certificate of deposit with a duration of 6 months [5]. - The company has previously raised RMB 2.5 billion through a non-public offering of shares, with a net amount of RMB 2.49 billion after deducting issuance costs [6]. Purpose of Cash Management - The purpose of cash management is to enhance the efficiency of fund utilization while ensuring the safety of funds and the normal operation of investment projects [3][10]. Risk Management - The company emphasizes that the cash management will only involve high-security and liquid products, minimizing investment risks [8][9]. - Strict adherence to prudent investment principles and confidentiality regarding cash management activities is mandated [9]. Impact on Company - The cash management activities are not expected to affect the implementation of investment projects or the company's future operations, financial status, or cash flow significantly [10].